L-carnitine is one of the supplements most associated with weight loss, and it has a real reason to be: it's what allows fats to enter the mitochondria, where muscle burns them to produce energy. The useful question is therefore precise: what do trials measure when given to people seeking to lose weight?
This guide brings together meta-analyses published from 2016 to 2025, including an umbrella meta-analysis that groups eight of them, trials that explain why the effect remains modest, what changes when taken at the time of a carbohydrate-rich meal, the dose associated with the best result, the timeframe to expect, and what the L-tartrate form brings to muscle recovery.
What meta-analyses measure : in adults, L-carnitine causes an average weight loss of 1.1 to 1.3 kg more than placebo over 8 to 30 weeks, and 1.2 to 2.1 kg more fat mass depending on the analyses. The effect mainly concerns overweight or obese individuals. It adds to caloric deficit and physical activity, it does not replace them.
Why the effect remains modest : carnitine only enters muscle through the action of insulin. Taken with carbohydrates twice daily, it increases muscle carnitine by approximately 20% in 12 weeks; in these trials, it increased fat utilization during exercise and prevented fat gain from excess carbohydrates. In practice : at meals containing starches, for at least 12 weeks, with the most noticeable effect observed around 2 g per day. The L-tartrate form additionally has positive trials on muscle recovery.
- L-carnitine, what it does in the body
- What meta-analyses show
- For whom the effect is most noticeable
- Why the effect remains modest: the muscle question
- What dose, how long, when to take it
- The L-tartrate form and recovery
- Tolerance: what you need to know
- The plan, in order
- Frequently asked questions
L-carnitine, what it does in the body
L-carnitine is a molecule that the body manufactures itself and that diet provides, mainly through red meat. Its role is specific: it transports long-chain fatty acids across the mitochondrial membrane, where they are oxidized to produce energy. Without it, muscle cannot use these fats as fuel.
The body guards its reserves carefully: the kidneys reabsorb 98 to 99% of the carnitine they filter. Carnitine from supplements is less well absorbed than that from food: 5 to 18% of a dose of 1 to 6 g enters the bloodstream, compared to up to 75% for small amounts provided by diet, according to the reference pharmacokinetics review. The muscle, finally, is the compartment that equilibrates most slowly: carnitine taken orally rises quickly in the blood, much more slowly in muscle fibers.
This is what makes the question interesting. The role of carnitine in fat utilization is established; trials make it possible to measure what a supplement provides in people seeking weight loss, and under what conditions.
What meta-analyses show
Thirty-seven randomized controlled trials, pooling 2,292 adults, were combined, with analysis of the effect according to dose. Compared to the control group, L-carnitine produced 1.21 kg more weight loss (95% confidence interval: 0.68 to 1.73 kg), lowered BMI by 0.24 kg/m² and fat mass by 2.08 kg. Waist circumference and fat percentage did not change significantly. Only the effect on weight persisted when the analysis was limited to high-quality trials. Maximum effect was observed at 2,000 mg per day, particularly in overweight or obese adults.
Talenezhad N, Mohammadi M, Ramezani-Jolfaie N, Mozaffari-Khosravi H, Salehi-Abargouei A. Clin Nutr ESPEN 2020;37:9-23. DOI: 10.1016/j.clnesp.2020.03.008
| Summary | Trials | Weight | Fat Mass | Waist Circumference |
|---|---|---|---|---|
| Obesity Reviews, 2016 | 9 trials, 911 adults | −1.33 kg | Not reported | Not reported |
| Clinical Nutrition ESPEN, 2020 | 37 trials, 2,292 adults | −1.21 kg | −2.08 kg | No significant effect |
| Pharmacological Research, 2020 | 43 trials | −1.13 kg | −1.16 kg | No significant effect |
| Umbrella meta-analysis, 2025 | 8 meta-analyses, 16,352 participants | Significant decrease | Not analyzed | Significant decrease |
The figures converge toward approximately one kilogram more than placebo, measured over trials lasting 8 to 30 weeks. This kilogram is in addition to what each group loses through the diet or activity proposed in the trials. Fat mass analyses point in the same direction, ranging from 1.2 to 2.1 kg according to the synthesis, whereas body fat percentage and waist circumference do not always change significantly; the 2025 umbrella meta-analysis, which groups eight meta-analyses, conversely finds a decrease in waist circumference, with zero variability between them on this criterion.
The pooled trials are heterogeneous: doses ranging from 150 mg to 4 g per day, durations of 8 to 30 weeks, varied populations, with or without associated diet. For weight, variability between results reaches 90% in the umbrella meta-analysis: the average effect is solid, its exact magnitude less so.
Two clarifications help with projections. In the 2016 synthesis, the difference from placebo decreased as trial duration increased: the effect is mainly visible in the first few months. And in the 2020 synthesis covering 37 trials, only the effect on weight persisted when the analysis was limited to higher-quality trials.
For whom the effect is most pronounced
The meta-analysis of 43 trials published in Pharmacological Research is clear: weight loss appears only in overweight or obese adults, not in dialysis patients. The 37-trial analysis also shows its maximum effect in overweight adults. Trials conducted in two common metabolic situations, polycystic ovary syndrome and type 2 diabetes, point in the same direction.
Sixty overweight women with polycystic ovary syndrome received 250 mg of carnitine daily or placebo for 12 weeks. Weight decreased by 2.7 kg with carnitine and increased by 0.1 kg with placebo; waist circumference decreased by 2.0 cm versus 0.3 cm (p < 0.001 for both). The HOMA-IR insulin resistance index decreased by 0.61, versus an increase of 0.11 with placebo (p = 0.04).
Samimi M, Jamilian M, Ebrahimi FA, Rahimi M, Tajbakhsh B, Asemi Z. Clin Endocrinol (Oxf) 2016;84(6):851-857. DOI: 10.1111/cen.13003
In people with type 2 diabetes, a meta-analysis of 21 trials and 2,041 patients, published in 2024, associates each daily gram of L-carnitine with a decrease in body mass index of 0.37 kg/m², with the strongest decrease observed at 2 g per day, showing small decreases in glycated hemoglobin and LDL-cholesterol. The authors urge caution due to the high variability of trials. Our article on PCOS and fertility details other avenues being studied in this syndrome.
Two trials found no effect, and they are instructive. In 36 moderately obese women who walked 30 minutes four times a week, 4 g of L-carnitine daily for 8 weeks changed neither weight nor fat mass compared to placebo; five women in the carnitine group discontinued due to nausea or diarrhea. In 28 active women aged 65 to 70, non-obese, 1,500 mg of L-carnitine L-tartrate daily for 24 weeks significantly increased blood carnitine, without notable changes in weight, muscle mass, or strength. These two trials remind us that carnitine's effect is modest: it is not apparent in a few weeks in a small trial, nor in people who have no weight to lose.
Why the effect remains modest: the muscle question
For muscle to burn more fat, carnitine must increase within the muscle. Yet its entry into the muscle fiber is stimulated by insulin, the hormone released when eating carbohydrates. A team at the University of Nottingham measured what it takes to achieve this, and what it changes.
Fourteen lean men took 2 g of L-carnitine L-tartrate twice daily with 80 g of carbohydrates, or carbohydrates alone, for 24 weeks. Muscle carnitine increased by 21% in the carnitine group. During exercise at 50% of maximal oxygen uptake, this group used 55% less muscle glycogen, indicating greater reliance on fat, and performance test work improved by 11%. These effects were significant only after 24 weeks.
Wall BT, Stephens FB, Constantin-Teodosiu D, Marimuthu K, Macdonald IA, Greenhaff PL. J Physiol 2011;589(Pt 4):963-973. DOI: 10.1113/jphysiol.2010.201343
Twelve healthy men took 1.36 g of L-carnitine twice daily with 80 g of carbohydrates, or carbohydrates alone, for 12 weeks. In the carnitine group, muscle carnitine increased by 20% and energy expenditure during moderate-intensity exercise by 6%. The control group, which thus received 160 g more carbohydrates daily, gained 1.9 kg, including 1.8 kg of fat measured by absorptiometry; weight and fat mass in the carnitine group did not change.
Stephens FB, Wall BT, Marimuthu K, et al. J Physiol 2013;591(18):4655-4666. DOI: 10.1113/jphysiol.2013.255364
Two other studies from the same team clarify the conditions. In seven young men, 3 g of L-carnitine followed by 80 g of carbohydrates led carnitine to enter the forearm muscle; replacing half the carbohydrates with 40 g of whey protein blocked this entry momentarily, despite comparable insulin levels. And in 14 men averaging 69 years old, 25 weeks of L-carnitine L-tartrate, 4.5 g daily in a beverage providing 44.4 g of carbohydrates and 13.8 g of protein, increased muscle carnitine by 20% and fat oxidation during moderate exercise by 20%.
These trials explain the order of magnitude in meta-analyses. Without carbohydrates to raise insulin, orally taken carnitine remains mostly in the blood before being eliminated by the kidneys; even under the best conditions, it takes approximately three months to load the muscle. They also show what carnitine does well: it directs muscle toward fat as fuel during moderate-intensity effort, and it prevented fat gain linked to excess carbohydrates.
Which dose, how long, at what time
| Benchmark | What the trials show | Source |
|---|---|---|
| Doses studied | From 150 mg to 4 g per day | Umbrella meta-analysis, 2025 |
| Best effect | Around 2 g of L-carnitine per day | Meta-analyses from 2020 and 2024 |
| Effect measured from | 250 mg per day, in women with PCOS | Randomized trial, 2016 |
| Equivalence | 3 g of L-carnitine L-tartrate provides 2 g of L-carnitine | Randomized trial, 2021 |
| Duration | 8 to 30 weeks for weight; 12 weeks to build muscle | Meta-analyses; trials from 2011 and 2013 |
| Timing | With carbohydrates, in two doses per day | Trials from 2011 and 2013 |
Two capsules of our L-carnitine provide 1,500 mg of L-carnitine L-tartrate, or approximately 1,000 mg of L-carnitine: a dose within the range used in trials, to which the meta-analysis in people with diabetes already associates a reduction in body mass index.
The timing of intake follows from the mechanism. Trials that built muscle paired each dose with carbohydrates, twice a day. Taking it at lunch and dinner, if they contain starches, bread, rice, pasta, potatoes, legumes, or fruits, reproduces these conditions without adding sugar. No trial compared morning, evening, or pre-workout timing; in the 2021 recovery trial, carnitine was taken at the first meal or thirty minutes before exercise.
For duration, weight trials ranged from 8 to 30 weeks and muscle loading requires approximately 12 weeks: three months is the minimum to judge results.
The L-tartrate form and recovery
L-carnitine L-tartrate is a salt of L-carnitine and tartaric acid, which provides approximately two-thirds of its weight in L-carnitine. It is the form used in several trials conducted in athletes, with a consistent result: better recovery after exercise that heavily stresses the muscle.
Ten men trained in weight training took L-carnitine L-tartrate providing 2 g of L-carnitine per day for three weeks, then placebo, or vice versa, before an intense weight training session. Under carnitine, markers of stress and muscle lesions—hypoxanthine, xanthine oxidase, myoglobin, and creatine kinase—increased less, and the area of visible muscle damage on MRI represented 41 to 45% of that measured under placebo.
Volek JS, Kraemer WJ, Rubin MR, Gómez AL, Ratamess NA, Gaynor P. Am J Physiol Endocrinol Metab 2002;282(2):E474-E482. DOI: 10.1152/ajpendo.00277.2001
Eighty active adults aged 21 to 65, men and women, took 3 g of L-carnitine L-tartrate per day, or 2 g of L-carnitine, or placebo for five weeks, then performed a session designed to cause muscle lesions. Creatine kinase, a marker of these lesions, was 28% higher under placebo, perceived recovery was worse, and losses of strength and power were greater, in both women and men. Adverse effects were as frequent as under placebo.
Stefan M, Sharp M, Gheith R, et al. Nutrients 2021;13(10):3432. DOI: 10.3390/nu13103432
Two authors of the 2021 trial work for the ingredient supplier, a point to note; its results align with those of the 2002 trial, conducted by another team. For someone losing weight while training, better recovery helps maintain workout intensity, and it is resistance training that protects muscle mass during a deficit. Our guide to muscle soreness details other recovery strategies.
Tolerance: what you need to know
The reference risk assessment, published in 2006, places the observed safety level at 2,000 mg of L-carnitine per day in prolonged use; higher doses were tested without adverse effects, but over periods considered too short to conclude on long-term safety. In the five-week trial at 2 g per day, adverse effects were as frequent as with placebo; at 4 g per day, nausea and diarrhea led five women to discontinue.
Healthy women aged 65 to 70 years took 1,500 mg of L-carnitine L-tartrate per day or placebo for 24 weeks. Plasma TMAO, a molecule produced by the intestinal microbiota from carnitine and studied as a cardiovascular risk marker, increased tenfold, with no change in CRP, interleukin 6, TNF-alpha, vascular adhesion molecules, or blood lipids. Four months after discontinuation, it had returned to the placebo group level.
Samulak JJ, et al. Ann Nutr Metab 2019;74(1):11-17. DOI : 10.1159/000495037 ; Nutrients 2019;11(6):1322. DOI : 10.3390/nu11061322
With anticoagulant antivitamin K therapy: two published cases describe an enhanced effect of acenocoumarol, and INR should be monitored at the beginning and upon discontinuation. With thyroid treatment: carnitine slows the action of thyroid hormones in cells, to the point that it has been tested against hormone excess. With valproate or in case of epilepsy, on dialysis or in case of kidney disease, during pregnancy or breastfeeding, and in case of cardiovascular disease, the decision should be made with your doctor.
The plan, in order
1,500 mg of L-carnitine L-tartrate per two capsules, approximately 1,000 mg of L-carnitine, a dose within the range of weight loss trials. At meals containing carbohydrates, for at least 12 weeks, as a complement to controlled eating and regular physical activity. Under medication or during pregnancy, consult your doctor.
See L-carnitineOur comparison of fat burners places L-carnitine among the other studied active ingredients.
Frequently Asked Questions
Does L-carnitine help you lose weight?
Yes, but modestly. In meta-analyses of randomized trials, it produces an average weight loss of 1.1 to 1.3 kg more than placebo over 8 to 30 weeks, with 1.2 to 2.1 kg less fat mass according to analyses. The effect primarily concerns overweight or obese adults, and it adds to a caloric deficit, which remains the driver of weight loss.
How many kilos can you lose with L-carnitine?
In addition to what the diet causes you to lose, approximately one kilo over several months: 1.21 kg in the meta-analysis of 37 trials, 1.13 kg in that of 43 trials, 1.33 kg in that of 9 trials. In the latter, the difference from placebo was more pronounced in the first months and decreased when trials lasted longer.
What dosage of L-carnitine for weight loss?
Trials tested 150 mg to 4 g per day. The most marked effect is observed around 2 g of L-carnitine per day, in the meta-analysis of 37 trials as well as in people with diabetes, and an effect was measured from 250 mg per day in women with polycystic ovary syndrome. 1,500 mg of L-carnitine L-tartrate provide approximately 1,000 mg of L-carnitine.
When to take L-carnitine: before exercise, with meals, in the evening?
At the time of meals that contain carbohydrates. Carnitine enters the muscle only through the action of insulin: trials that increased muscle carnitine paired it with carbohydrates, twice a day. No trial compared morning, evening, or pre-workout timing; taken at dinner, if it contains starches, it remains consistent with this mechanism.
How long before seeing results?
Count on at least three months. Taken with carbohydrates, L-carnitine increases muscle carnitine by approximately 20% in 12 weeks and 21% in 24 weeks. Weight loss trials lasted 8 to 30 weeks. Effects on muscle recovery appear in 3 to 5 weeks.
Does L-carnitine work without exercise?
Meta-analyses group trials conducted with or without diet and exercise programs; they do not allow isolating the effect of carnitine alone in a sedentary person. In muscle trials, carnitine increased fat utilization during moderate-intensity exercise: walking, cycling, easy-paced running. Physical activity therefore remains the best ally of supplementation.
Is L-carnitine effective in women?
In overweight women with polycystic ovary syndrome, 250 mg per day for 12 weeks resulted in a loss of 2.7 kg, compared to a gain of 0.1 kg under placebo. In moderately obese women who walked four times per week, 4 g per day for 8 weeks changed nothing, and in women aged 65 to 70 years without obesity, 24 weeks did not alter body composition. On muscle recovery, the 5-week trial showed a benefit in women as well as men.
L-carnitine or L-carnitine L-tartrate: what's the difference?
L-carnitine L-tartrate is a salt of L-carnitine and tartaric acid: 3 g of L-carnitine L-tartrate provides 2 g of L-carnitine. It is the form used in several trials on muscle carnitine loading and in recovery trials, where it reduced muscle damage markers after exercise.
Does L-carnitine have side effects?
It is well tolerated at the studied doses: at 2 g per day for 5 weeks, adverse effects were as frequent as with placebo, and the reference assessment sets 2,000 mg per day as the safety level observed with prolonged use. At 4 g per day, nausea and diarrhea have been reported. It increases blood TMAO, a marker studied in cardiology, reversibly upon discontinuation. Medical advice recommended if taking anticoagulant vitamin K antagonists or thyroid treatment.
What to remember about L-carnitine and weight loss?
That it has a real and modest effect, of approximately one kilo more than placebo, especially in overweight individuals. That it works in support of a caloric deficit and physical activity, without replacing them. That it is taken with meals containing carbohydrates, for at least 12 weeks, with the most pronounced effect observed around 2 g per day. And that the L-tartrate form additionally helps with exercise recovery.
Sources
The studies cited below were identified via PubMed.
- Evans AM, Fornasini G. Pharmacokinetics of L-carnitine. Clinical Pharmacokinetics, 2003;42(11):941-967. DOI
- Talenezhad N, Mohammadi M, Ramezani-Jolfaie N, Mozaffari-Khosravi H, Salehi-Abargouei A. Effects of L-carnitine on weight loss and body composition: systematic review and meta-analysis of 37 randomized trials with dose-response analysis. Clinical Nutrition ESPEN, 2020;37:9-23. DOI
- Pooyandjoo M, Nouhi M, Shab-Bidar S, Djafarian K, Olyaeemanesh A. Effect of (L-)carnitine on weight loss in adults: systematic review and meta-analysis of randomized trials. Obesity Reviews, 2016;17(10):970-976. DOI
- Askarpour M, Hadi A, Miraghajani M, Symonds ME, Sheikhi A, Ghaedi E. Effects of L-carnitine on weight management in overweight or obese adults: an updated systematic review and dose-response meta-analysis of randomized trials. Pharmacological Research, 2020;151:104554. DOI
- Hamedi-Kalajahi F, Zarezadeh M, Malekahmadi M, et al. Effect of L-carnitine on obesity indices: an umbrella meta-analysis. International Journal for Vitamin and Nutrition Research, 2025;95(2):40033. DOI
- Samimi M, Jamilian M, Ebrahimi FA, Rahimi M, Tajbakhsh B, Asemi Z. Oral carnitine reduces weight and insulin resistance in women with polycystic ovary syndrome: a randomized double-blind placebo-controlled trial. Clinical Endocrinology, 2016;84(6):851-857. DOI
- Mirrafiei A, Jayedi A, Shab-Bidar S. Effects of L-carnitine on weight loss, glycemic control, and cardiovascular risk factors in type 2 diabetes: a systematic review and dose-response meta-analysis. Clinical Therapeutics, 2024;46(5):404-410. DOI
- Villani RG, Gannon J, Self M, Rich PA. L-carnitine combined with aerobic training does not promote weight loss in moderately obese women. International Journal of Sport Nutrition and Exercise Metabolism, 2000;10(2):199-207. DOI
- Sawicka AK, Hartmane D, Lipinska P, Wojtowicz E, Lysiak-Szydlowska W, Olek RA. L-carnitine in older women: a pilot study on muscle mass and function. Nutrients, 2018;10(2):255. DOI
- Wall BT, Stephens FB, Constantin-Teodosiu D, Marimuthu K, Macdonald IA, Greenhaff PL. Prolonged L-carnitine and carbohydrate ingestion increases muscle carnitine content and alters substrate utilization during exercise. Journal of Physiology, 2011;589(Pt 4):963-973. DOI
- Stephens FB, Wall BT, Marimuthu K, et al. Muscle carnitine loading increases energy expenditure, modulates energy metabolism genes, and prevents fat accumulation. Journal of Physiology, 2013;591(18):4655-4666. DOI
- Shannon CE, Nixon AV, Greenhaff PL, Stephens FB. Protein ingestion acutely inhibits insulin-stimulated muscle carnitine uptake in young men. American Journal of Clinical Nutrition, 2016;103(1):276-282. DOI
- Chee C, Shannon CE, Burns A, et al. Increasing muscle carnitine in older adults increases fat oxidation during moderate-intensity exercise. Aging Cell, 2021;20(2):e13303. DOI
- Stefan M, Sharp M, Gheith R, et al. Five weeks of L-carnitine L-tartrate improve post-exercise recovery in men and women: a randomized double-blind placebo-controlled trial. Nutrients, 2021;13(10):3432. DOI
- Volek JS, Kraemer WJ, Rubin MR, Gómez AL, Ratamess NA, Gaynor P. L-carnitine L-tartrate improves recovery markers following exercise stress. American Journal of Physiology. Endocrinology and Metabolism, 2002;282(2):E474-E482. DOI
- Hathcock JN, Shao A. Risk assessment of carnitine. Regulatory Toxicology and Pharmacology, 2006;46(1):23-28. DOI
- Samulak JJ, Sawicka AK, Hartmane D, et al. L-carnitine increases TMAO but not atherosclerosis markers in healthy elderly women. Annals of Nutrition and Metabolism, 2019;74(1):11-17. DOI
- Samulak JJ, Sawicka AK, Samborowska E, Olek RA. Plasma TMAO after L-carnitine discontinuation in healthy elderly women. Nutrients, 2019;11(6):1322. DOI
- Bachmann HU, Hoffmann A. Interaction of dietary supplement L-carnitine with oral anticoagulant acenocoumarol. Swiss Medical Weekly, 2004;134(25-26):385. DOI
- Benvenga S, Ruggeri RM, Russo A, Lapa D, Campenni A, Trimarchi F. Benefit of L-carnitine, natural peripheral antagonist of thyroid hormone action, in iatrogenic hyperthyroidism: a randomized double-blind placebo-controlled trial. Journal of Clinical Endocrinology and Metabolism, 2001;86(8):3579-3594. DOI


